Search

Dr Reddy's Laboratories Ltd-ADR

Cerrado

SectorSanidad

11.96 -0.58

Resumen

Variación precio

24h

Actual

Mínimo

11.94

Máximo

12.03

Métricas clave

By Trading Economics

Ingresos

2.1B

4.3B

Ventas

4.9B

81B

P/B

Media del Sector

29.585

56.659

BPA

0.06

Rentabilidad por dividendo

0.68

Margen de beneficios

5.356

Empleados

27,527

EBITDA

-5.8B

3B

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+35.33% upside

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

0.68%

2.18%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-330M

10B

Apertura anterior

12.54

Cierre anterior

11.96

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

143 / 339 Clasificación en Healthcare

Dr Reddy's Laboratories Ltd-ADR Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

4 sept 2026, 23:40 UTC

News

DocuSign Inc. reported strong second-quarter results and raised guidance, yet shares are trading lower in after-market hours amid valuation concerns and economic context.

4 sept 2026, 23:35 UTC

News

AAP shares lower in after-market hours on analyst rating updates.

4 sept 2026, 23:27 UTC

News

Photronics Inc shares traded lower in after-market hours amid a securities class action lawsuit alleging fraud related to its product pipeline and demand stability.

4 sept 2026, 23:20 UTC

News

Monster Beverage appoints Matthew S. Burroughs as Chief Accounting Officer and Deputy CFO, with shares rising in after-market trading.

4 sept 2026, 23:10 UTC

News

Northrop Grumman was awarded a $508.49 million contract for flight test support by the U.S. Department of Defense, shares trading higher in after-market hours.

4 sept 2026, 23:05 UTC

News

Pomerantz LLP filed a class action lawsuit against Replimune Group Inc for alleged securities fraud, contributing to a decline in shares during after-market hours.

4 sept 2026, 23:02 UTC

News

Illumina Inc will join the S&P 500 index effective September 21, 2026, following an announcement by Dow Jones Indices. Shares are trading higher after the news.

4 sept 2026, 23:02 UTC

Social Media
News

Star Bulk Carriers announced a parallel listing on Euronext Athens and an equity offering. Shares are lower in after-market hours following the news.

4 sept 2026, 23:02 UTC

News

Ionis Pharmaceuticals shares declined in after-market trading following Novartis' announcement of the failed pelacarsen Phase 3 study to reduce cardiovascular events.

4 sept 2026, 23:00 UTC

News

Bloom Energy shares are higher in after-market trading following its inclusion in the S&P 500, effective September 21, 2026.

4 sept 2026, 23:00 UTC

News

FirstEnergy shares rise in after-market trading following Potomac Edison's $52.8 million rate adjustment proposal to enhance electric system reliability in Maryland.

4 sept 2026, 23:00 UTC

News

Campbell's Co announced a restructuring plan, cutting 13% of salaried jobs and closing two plants. Shares are trading higher in after-market hours.

4 sept 2026, 22:51 UTC

Correlated Moves
News

Shares rose in after-market trading amid strength in oil sector.

4 sept 2026, 20:08 UTC

News

Planet Fitness Inc. is facing a securities class action lawsuit alleging misleading statements on customer growth, contributing to a decline in its stock during Friday's session.

4 sept 2026, 20:08 UTC

News
Correlated Moves

Marten Transport Ltd shares are higher, supported by a broader transportation sector rally and an amended credit facility increasing the letters-of-credit sublimit to $50 million.

4 sept 2026, 20:08 UTC

News

Jefferies Financial Group's shares are higher as it maintains "buy" ratings and raises price targets for several banks, including Barclays and Lloyds.

4 sept 2026, 20:08 UTC

News

El Pollo Loco Holdings to participate in two investor conferences this month. Shares are trading higher, reflecting positive sentiment despite earlier session pullback.

4 sept 2026, 20:08 UTC

News

Intuitive Surgical shares declined to $365.21, marking a four-week low. Ongoing market challenges contributed to the stock's downward movement during the session.

4 sept 2026, 20:08 UTC

News
Social Media
Macro Event

McDonald's shares hit a 52-week low amid ongoing challenges, including high menu prices like $15 for an Egg McMuffin, reflecting a broader market decline.

4 sept 2026, 20:08 UTC

News

OrthoPediatrics Corp shares are lower amid broader market declines and selling pressure following a strong jobs report. A major shareholder's recent sale adds to negative sentiment.

4 sept 2026, 20:08 UTC

Social Media
Macro Event
News
Correlated Moves

Intel shares are higher as demand for CPUs surges, driven by AI workloads. Despite a price target cut to $92, investor sentiment remains positive.

4 sept 2026, 20:08 UTC

News
Correlated Moves
Social Media

Advanced Micro Devices is rising as AI demand boosts projections for its EPYC CPUs, aided by partnerships like Microsoft’s Project Zenith.

4 sept 2026, 20:08 UTC

News

Globus Medical Inc received CE mark approval for its Excelsius3D system, enabling sales in the EU and U.K. Shares are gaining during Friday's session.

4 sept 2026, 20:08 UTC

News

PVH Corp reported a second-quarter loss of $102.9 million but shares are higher today, rebounding after an earlier dip during the session.

4 sept 2026, 20:08 UTC

News
Correlated Moves

Douglas Dynamics declared a quarterly dividend of $0.295 per share, with shares rising today alongside Astec Industries' notable gain.

4 sept 2026, 20:08 UTC

Macro Event
Social Media
News

Dell Technologies reported strong quarterly earnings, with revenue rising significantly. The stock reached a record high amid positive sentiment following the earnings beat.

4 sept 2026, 20:08 UTC

News

Ollie's Bargain Outlet reported Q2 EPS of $1.42, surpassing estimates. Shares are higher amid positive sentiment following the earnings announcement.

4 sept 2026, 20:08 UTC

News

Airbnb Inc. shares are declining as the EU proposes regulations on short-term rentals to address affordable housing shortages in tourist areas.

4 sept 2026, 20:08 UTC

News

UnitedHealth Group will cut prior-authorization requirements across plans starting October 1. Shares are lower today, in line with broader market declines.

4 sept 2026, 20:08 UTC

News

Teladoc Health Inc shares are lower today amid broader market declines following a strong jobs report raising concerns over tighter monetary policy.

Comparación entre iguales

Cambio de precio

Dr Reddy's Laboratories Ltd-ADR previsión

Precio Objetivo

By TipRanks

35.33% repunte

Estimación a 12 Meses

Media 16.28 USD  35.33%

Máximo 16.276 USD

Mínimo 16.276 USD

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Dr Reddy's Laboratories Ltd-ADR Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

1 ratings

1

Comprar

0

Mantener

0

Vender

Sentimiento

By Acuity

143 / 339 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Dr Reddy's Laboratories Ltd-ADR

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
help-icon Live chat